Share on LinkedInShare on LinkedIn

ARTICLE · 14 DECEMBER 2018

2018 In Review – Inter Partes Review Developments, Part 2 Of 2

Following the Oil States decision in which the Supreme Court invoked the public rights doctrine to protect the Patent Trial and Appeal Board's (PTAB) authority to invalidate patents by inter partes review (IPR).

United StatesIntellectual Property

IPR and Tribal Sovereign Immunity

Following the Oil States decision in which the Supreme Court invoked the public rights doctrine to protect the Patent Trial and Appeal Board's (PTAB) authority to invalidate patents by inter partes review (IPR), the Federal Circuit used a similar line of reasoning to determine whether tribal sovereign immunity could bar this form of patent review.

Saint Regis Mohawk Tribe v Mylan Pharms. Inc originated as a patent infringement dispute between private pharmaceutical companies Allergan and Mylan. Mylan challenged the Allergan patents in an IPR. A week before the PTAB was to hear arguments in the IPR proceeding, Allergan assigned the patents to the Saint Regis Mohawk Tribe, which then sought to terminate the IPR by asserting tribal sovereign immunity.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from